These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study. Bornhäuser M; Kröger N; Schwerdtfeger R; Schafer-Eckart K; Sayer HG; Scheid C; Stelljes M; Kienast J; Mundhenk P; Fruehauf S; Kiehl MG; Wandt H; Theuser C; Ehninger G; Zander AR; Eur J Haematol; 2006 Jan; 76(1):9-17. PubMed ID: 16343266 [TBL] [Abstract][Full Text] [Related]
9. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen. Takami A; Chuhjo T; Nakao S Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925 [No Abstract] [Full Text] [Related]
10. Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib. Prebet T; Tigaud I; Hayette S; Clapisson G; Philip I; Michallet M; Nicolini FE Haematologica; 2005 Nov; 90 Suppl():ECR36. PubMed ID: 16266927 [No Abstract] [Full Text] [Related]
11. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts. Yang H; Eaves C; de Lima M; Lee MS; Champlin RE; McMannis JD; Robinson SN; Niu T; Decker WK; Xing D; Ng J; Li S; Yao X; Eaves AC; Jones R; Andersson BS; Shpall EJ Bone Marrow Transplant; 2006 Mar; 37(6):575-82. PubMed ID: 16435011 [TBL] [Abstract][Full Text] [Related]
13. Busulphan and melphalan prior to autologous transplantation for myeloid malignancies. Cony-Makhoul P; Marit G; Boiron JM; Puntous M; Reiffers J Bone Marrow Transplant; 1995 Jul; 16(1):69-70. PubMed ID: 7581131 [TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia. Carella AM Expert Rev Anticancer Ther; 2007 Mar; 7(3):249-51. PubMed ID: 17338645 [No Abstract] [Full Text] [Related]
15. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study. de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253 [TBL] [Abstract][Full Text] [Related]
16. Intensive chemotherapy and autologous hematopoietic stem cell mobilization, collection and transplantation with simultaneous Imatinib therapy in patients with blast crisis chronic myeloid leukaemia. Heim D; Friess D; Christen S; Stüssi G; Meyer-Monard S; Tichelli A; Passweg JR; Gratwohl A Leukemia; 2006 May; 20(5):898-900. PubMed ID: 16525490 [No Abstract] [Full Text] [Related]
18. Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias. Tiribelli M; Marin L; Calistri E; Geromin A; Damiani D; Fanin R Bone Marrow Transplant; 2004 Nov; 34(9):827-8. PubMed ID: 15334052 [No Abstract] [Full Text] [Related]
19. Interferon in chronic myeloid leukaemia: past and future. Guilhot F; Roy L; Saulnier PJ; Guilhot J Best Pract Res Clin Haematol; 2009 Sep; 22(3):315-29. PubMed ID: 19959083 [TBL] [Abstract][Full Text] [Related]
20. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides]. Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]